title: Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.
abstract: Tuberculosis is the oldest of the world's current pandemics and causes 8.9 million new cases and 1.7 million deaths annually. The disease is among the most common causes of morbidity and mortality in people living with HIV. However, tuberculosis is more than just part of the global HIV problem; well-resourced tuberculosis programmes are an important part of the solution to scaling-up towards universal access to comprehensive HIV prevention, diagnosis, care, and support. This article reviews the impact of the interactions between tuberculosis and HIV in resource-limited settings; outlines the recommended programmatic and clinical responses to the dual epidemics, highlighting the role of tuberculosis/HIV collaboration in increasing access to prevention, diagnostic, and treatment services; and reviews progress in the global response to the epidemic of HIV-related tuberculosis.
authors.affiliation: Stop TB Department, WHO, Geneva, Switzerland.
authors.forename: Alasdair
authors.initials: A
authors.lastname: Reid
authors.forename: Fabio
authors.initials: F
authors.lastname: Scano
authors.forename: Haileyesus
authors.initials: H
authors.lastname: Getahun
authors.forename: Brian
authors.initials: B
authors.lastname: Williams
authors.forename: Christopher
authors.initials: C
authors.lastname: Dye
authors.forename: Paul
authors.initials: P
authors.lastname: Nunn
authors.forename: Kevin M
authors.initials: KM
authors.lastname: De Cock
authors.forename: Catherine
authors.initials: C
authors.lastname: Hankins
authors.forename: Bess
authors.initials: B
authors.lastname: Miller
authors.forename: Kenneth G
authors.initials: KG
authors.lastname: Castro
authors.forename: Mario C
authors.initials: MC
authors.lastname: Raviglione
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004196:Disease Outbreaks; D014943:Global Health; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D015995:Prevalence; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents